Načítá se...
Plasma metabolomics and clinical predictors of survival differences in COPD patients
BACKGROUND: Plasma metabolomics profile (PMP) in COPD has been associated with clinical characteristics, but PMP’s relationship to survival has not been reported. We determined PMP differences between patients with COPD who died an average of 2 years after enrollment (Non-survivors, NS) compared to...
Uloženo v:
| Vydáno v: | Respir Res |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6794856/ https://ncbi.nlm.nih.gov/pubmed/31615518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-019-1167-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|